PreciseDx pricing
PreciseDx bills PreciseBreast per test under its own billing code and says it costs 30 percent of gene expression testing, which its home page puts at more than $4,000, without stating its own charge. Patients can apply to an assistance program or spread costs over up to six months. No list price or expected out of pocket cost under a plan is published.
How PreciseDx pricing works
- Pricing model
- Per test laboratory billing under CPT 0220U; insurance coverage varies by plan; patient assistance program and interest free payment plans up to six months. No list price published.
- Implementation
- None for the ordering practice; the test is a laboratory service.
- Business associate agreement
- Covered entity laboratory: a HIPAA Notice of Privacy Practices (effective 1 March 2025) is published; no business associate agreement for partners is published.
PreciseDx pricing against its alternatives
Published prices for PreciseDx and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.
- PPreciseDxNo published price
- SStratipathNo published price
- AArteraAINo list price published; patient cost $0 to $285 under the financial assistance program, and none for covered Medicare patients
- IImagene AINo published price
- WWaivNo published price
- VVeracyteNo published price
- PPrimaaNo published price
- DDoMore DiagnosticsNo published price
- LLunit SCOPENo published price
PreciseDx pricing, answered
How much does PreciseDx cost?
PreciseDx does not publish a price. PreciseDx bills PreciseBreast per test under its own billing code and says it costs 30 percent of gene expression testing, which its home page puts at more than $4,000, without stating its own charge. Patients can apply to an assistance program or spread costs over up to six months.
Does PreciseDx charge an implementation fee?
None for the ordering practice; the test is a laboratory service.
Does PreciseDx offer a business associate agreement?
Covered entity laboratory: a HIPAA Notice of Privacy Practices (effective 1 March 2025) is published; no business associate agreement for partners is published.